Net Cash Provided by (Used in) Investing Activities in USD of Propanc Biopharma, Inc. from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Propanc Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and change rate from 2011 to Q3 2025.
  • Propanc Biopharma, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending 30 Sep 2025 was -$2.49K.
  • Propanc Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2019 was -$2.87K.
  • Propanc Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2015 was -$5.59K.
  • Propanc Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2014 was $0.000.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)

Propanc Biopharma, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$2.49K 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q3 2015 -$679 -$679 01 Jul 2015 30 Sep 2015 10-Q 16 Nov 2015
Q3 2014 $0 $0 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015
Q3 2013 $0 01 Jul 2013 30 Sep 2013 10-Q 19 Nov 2014

Propanc Biopharma, Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2019 -$2.87K 01 Jul 2018 30 Jun 2019 10-K 01 Oct 2020
2015 -$5.59K -$5.59K 01 Jul 2014 30 Jun 2015 10-K 30 Sep 2015
2014 $0 01 Jul 2013 30 Jun 2014 10-K 30 Sep 2015
2011 -$29.2K 01 Jul 2010 30 Jun 2011 10-K 15 Oct 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.